Cyclophosphamide

In some countries, this medicine may only be approved for veterinary use.

In the US, Cyclophosphamide (cyclophosphamide systemic) is a member of the drug class alkylating agents and is used to treat Acute Lymphocytic Leukemia, Acute Nonlymphocytic Leukemia, Bladder Cancer, Brain Tumor, Breast Cancer, Bullous Pemphigoid, Cancer, Cervical Cancer, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Cogan's Syndrome, Dermatomyositis, Endometrial Cancer, Ewing's Sarcoma, Histiocytosis, Hodgkin's Lymphoma, IgA Nephropathy, Multiple Myeloma, Multiple Sclerosis, Mycosis Fungoides, Nephrotic Syndrome, Neuroblastoma, Non-Hodgkin's Lymphoma, Non-Small Cell Lung Cancer, Organ Transplant - Rejection Prophylaxis, Osteosarcoma, Ovarian Cancer, Pemphigoid, Pemphigus, Prostate Cancer, Rheumatoid Arthritis, Small Cell Lung Cancer, Systemic Lupus Erythematosus, Systemic Sclerosis, Testicular Cancer, Wegener's Granulomatosus and Wilms' Tumor.

US matches:

• Cyclophosphamide


• Cyclophosphamide Tablets


• Cyclophosphamide oral/injection


• Cyclophosphamide Oral, Intravenous


• Cyclophosphamide Injection

UK matches:

• Cyclophosphamide 50 Tablets (SPC)

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01AA01

CAS registry number (Chemical Abstracts Service)

0000050-18-0

Chemical Formula

C7-H15-Cl2-N2-O2-P

Molecular Weight

261

Therapeutic Categories

Disease-modifying antirheumatic drug, DMARD

Antineoplastic agent, alkylating agent

Chemical Name

2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide

Foreign Names

• Cyclophosphamidum (Latin)
• Cyclophosphamid (German)
• Cyclophosphamide (French)
• Ciclofosfamida (Spanish)

Generic Names

• Cyclophosphamide (OS: DCF, BAN)
• B 518 (IS)
• CYP (IS)
• Ledoxina (IS)
• NSC 26271 (IS)
• Cyclophosphamide (PH: JP XIV, BP 2010, Ph. Int. 4, USP 30, Ph. Eur. 6)
• Ciclofosfamide (PH: Ph. Eur. 6)
• Cyclophosphamid (PH: Ph. Eur. 6, USP 32)
• Cyclophosphamide Hydrate (PH: JP XV)
• Cyclophosphamidum (PH: Ph. Int. 4, Ph. Eur. 6)

Brand Names

• Alkyloxan
  Onko-Koçsel, Turkey



• Biodoxan
  Biogalenic, Venezuela



• Ciclofosfamida Dosa
  Dosa, Argentina



• Ciclofosfamida Filaxis
  Filaxis, Argentina



• Ciclofosfamida L.CH.
  Chile, Chile



• Ciclofosfamida Martian
  LKM, Argentina



• Ciclofosfamida Microsules
  Microsules, Argentina



• Ciclofosfamida
  Bestpharma, Chile; Kampar, Chile; Palmagyar, Peru; World Pharma, Peru



• Cycloblastin
  Pfizer, Australia



• Cyclogal
  Galenika, Serbia



• Cyclophosphamid A-Pharma
  Baxter, Denmark



• Cyclophosphamide
  Baxter, United States; Kalbe, Indonesia; Roxane, United States



• Cyclophosphan-Lens
  Verofarm, Georgia



• Cyclovid
  Novell, Indonesia



• Cycloxan
  Biochem, India



• Cycram
  Korea United Pharm, Georgia



• Cyloblastin
  Pfizer, New Zealand



• Cytophosphan
  Taro, Israel



• Cytoxan
  Baxter Healthcare, United States; Bristol-Myers Squibb, Bulgaria; Bristol-Myers Squibb, Canada; Bristol-Myers Squibb, Colombia; Bristol-Myers Squibb, Philippines; Bristol-Myers Squibb, Serbia



• Endoxan Baxter
  Baxter, Austria



• Endoxan
  All-Gen, Netherlands; ASTA Medica, Bangladesh; ASTA Medica, Tunisia; Aventis, South Africa; Baxter, Australia; Baxter, Belgium; Baxter, Chile; Baxter, France; Baxter, Hong Kong; Baxter, Israel; Baxter, Lithuania; Baxter, Luxembourg; Baxter, Latvia; Baxter, Netherlands; Baxter, New Zealand; Baxter, Serbia; Baxter, Slovenia; Baxter, Tunisia; Baxter, Taiwan; Baxter Oncology, Oman; Baxter Oncology, Poland; Baxter Oncology, Singapore; Eczacibasi Baxter, Turkey; German Remedies, India; Transfarma Medica Indah, Indonesia



• Endoxana
  ASTA Medica, Ireland; Baxter, United Arab Emirates; Baxter, Bahrain; Baxter, Egypt; Baxter, Iraq; Baxter, Iran; Baxter, Jordan; Baxter, Kuwait; Baxter, Lebanon; Baxter, Qatar; Baxter, Saudi Arabia; Baxter, Syria; Baxter, Yemen; Baxter Oncology, United Kingdom; Baxter Oncology, Oman



• Endoxana (veterinary use)
  Baxter, United Kingdom



• Endoxan-Asta
  ASTA Medica, United Arab Emirates; ASTA Medica, Bahrain; ASTA Medica, Cyprus; ASTA Medica, Egypt; ASTA Medica, Iraq; ASTA Medica, Jordan; ASTA Medica, Kuwait; ASTA Medica, Lebanon; ASTA Medica, Sri Lanka; ASTA Medica, Libya; ASTA Medica, Qatar; ASTA Medica, Saudi Arabia; ASTA Medica, Sudan; ASTA Medica, Syria; ASTA Medica, Yemen



• Genoxal
  Baxter, Spain



• Ledoxan
  Dabur, Philippines



• Ledoxina
  Chile, Chile



• Oncomide
  Khandelwal, Myanmar



• Procytox
  Baxter, Canada



• Sendoxan
  Baxter, Denmark; Baxter, Iceland



• Syklofosfamid
  Atafarm, Turkey; Orion, Taiwan



• Cryofaxol
  Cryopharma, Mexico



• Cyclophosphamide
  Orion, Czech Republic; Pfizer, United Kingdom



• Cytoxan
  Bristol-Myers Squibb, Hungary



• Endoxan Baxter
  Baxter, Austria; Baxter Oncology-D, Italy



• Endoxan
  Agmar, Croatia (Hrvatska); Asta Medica, Bulgaria; Baxter, Belgium; Baxter, Bulgaria; Baxter, Switzerland; Baxter, Czech Republic; Baxter, Estonia; Baxter, France; Baxter, Greece; Baxter, Hong Kong; Baxter, Hungary; Baxter, Luxembourg; Baxter, Netherlands; Baxter, Romania; Baxter, Slovakia; Baxter, Vietnam; Baxter Oncology, Germany; Shionogi Seiyaku, Japan; Sindan, Romania



• Endoxan P
  Shionogi Seiyaku, Japan



• Endoxana
  Baxter, Malta



• Ledoxina
  Lemery, Mexico



• Sendoxan
  Baxter, Finland; Baxter, Norway; Baxter, Sweden



• Syklofosfamid
  Orion, Estonia; Orion, Finland

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.